Concepedia

Joshua Gustine

JG

39

Publications

2K

Citations

24

H-Index

2015

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Boston University

Massachusetts General Hospital

Memorial Sloan Kettering Cancer Center

Joshua Gustine is an author at Dana-Farber Cancer Institute specializing in medicine, hematology, and pathology.

ORCID

Top concepts

Publications per year

2015–2023

39

Publications

39

Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia

Steven P. Treon, Joshua Gustine, Kirsten Meid et al. · Journal of Clinical Oncology · 2018 · 171 citations · Full text

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia

Steven P. Treon, Kirsten Meid, Joshua Gustine et al. · Journal of Clinical Oncology · 2020 · 142 citations · Full text

Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia

Lian Xu, Nicholas Tsakmaklis, Guang Yang et al. · Blood · 2017 · 136 citations · Full text

<i><scp>MYD</scp>88</i> wild‐type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival

Steven P. Treon, Joshua Gustine, Lian Xu et al. · British Journal of Haematology · 2017 · 101 citations · Full text

<i>CXCR4</i> mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib

Jorge J. Castillo, Lian Xu, Joshua Gustine et al. · British Journal of Haematology · 2019 · 98 citations · Full text

Rows per page

1–5 of 39